How to Cite
Abstract
Cryptococcal meningitis is a serious infection of the central nervous system caused mainly by Cryptococcus neoformans and Cryptococcus gatti that occurs mainly in immunosuppressed patients, especially in patients with HIV. It causes many AIDS-related deaths worldwide. Diagnosis is made by isolation of the fungus in cerebrospinal fluid culture or identification of cryptococcal antigen in blood tests. Early detection and therapeutic intervention is necessary to significantly improve patient survival and quality of life.
Keywords
References
Barquero M. Meningitis por cryptococcus neoformans: Revista médica de Costa Rica y Centroamérica. 2016, LXXIII (619) 205 – 208. [accesado 17 Mayo 2021]. Disponible https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2016/rmc162c.pdf
Pasquier E, Kunda J, De Beaudrap P, Loyse A, Temfack E, Molloy S et al. Long term mortality and disability in Cryptococcal Meningitis: a systematic literature review. Clinical Infectious Diseases [Internet]. 2017 [cited 4 April 2020];. Available from: https://academic.oup.com/cid/article/66/7/1122/4344944?searchresult=1
Pullen M, Hullsiek K, Rhein J, Musubire A, Tugume L, Nuwagira E et al. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials. Clinical Infectious Diseases [Internet]. 2020 [cited 4 April 2020];. Available from: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa016/5698219?redirectedFrom=fulltext
Offiah C, Naseer A. Spectrum of imaging appearances of intracranial cryptococcal infection in HIV/AIDS patients in the anti-retroviral therapy era. Clinical Radiology [Internet]. 2016 [cited 9 August 2020];71(1):9-17. Available from: https://www.sciencedirect.com/science/article/abs/pii/S000992601500392X
Beardsley J, Wolbers M, Kibengo F, Ggayi A, Kamali A, Cuc N et al. Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis. New England Journal of Medicine [Internet]. 2016 [cited 5 April 2020];374(6):542-554. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1509024
Molloy S, Kanyama C, Heyderman R, Loyse A, Kouanfack C, Chanda D et al. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. New England Journal of Medicine [Internet]. 2018 [cited 5 April 2020];378(11):1004-1017. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1710922
Barcia Castilla V, Sanchez Giler S. Utilidad de la prueba de tinta china como tamizaje para meningitis por Cryptococcus spp / Utility of indian ink as screening for meningitis by Cryptococcus spp. Ciencia Unemi [Internet]. 2016 [cited 3 April 2020];9(20):63. Available from: https://dialnet.unirioja.es/servlet/articulo?codigo=5774761
Pontello N, Gleichgerrcht E, Facundo M, Sinay V. Criptococosis meníngea en inmunosuprimidos: rol del síndrome inflamatorio de reconstitución inmune. Neurología Argentina [Internet]. 2012 [cited 19 February 2020];4(1):31-34. Available from: https://www.elsevier.es/es-revista-neurologia-argentina-301-articulo-criptococosis-meningea-inmunosuprimidos-rol-del-S1853002811000668
Rivero D, Scherle C, Loza G, Pillajo G, Pernas Y. Meningitis Criptocócica. Diferentes Contextos Clínicos y Complicaciones. Serie de 7 Casos. Revista Ecuatoriana de Neurología. 2019 (citado el 19 de febrero de 2020). Vol. 28, Nº2. Disponible en: http://revecuatneurol.com/wp-content/uploads/2019/10/2631-2581-rneuro-28-02-00028.pdf
Temfack E, Bigna J, Luma H, Spijker R, Meintjes G, Jarvis J et al. Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus–infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis. Clinical Infectious Diseases [Internet]. 2018 [cited 4 April 2020];68(4):688-698. Available from: https://academic.oup.com/cid/article/68/4/688/5055339?searchresult=1
Mpoza E, Rajasingham R, Tugume L, Rhein J, Nabaggala M, Ssewanyana I et al. Cryptococcal Antigenemia in HIV therapy-experienced Ugandans with Virologic Failure. Clinical Infectious Diseases [Internet]. 2019 [cited 4 April 2020];. Available from: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz1069/5611261?searchresult=1
Ssebambulidde K, Bangdiwala A, Kwizera R, Kandole T, Tugume L, Kiggundu R et al. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis. Clinical Infectious Diseases [Internet]. 2018 [cited 4 April 2020];68(12):2094-2098. Available from: https://academic.oup.com/cid/article-abstract/68/12/2094/5106758?redirectedFrom=fulltext
World Health Organization. The diagnosis, prevention and management of cryptococcal disease in hiv-infected adults, adolescents and children. Netherlands: World Health Organization ; 2018.
Wake R, Govender N, Omar T, Nel C, Mazanderani A, Karat A et al. Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program. Clinical Infectious Diseases [Internet]. 2019 [cited 4 April 2020];. Available from: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciz485/5513150?redirectedFrom=fulltext
Trejo-Espino A, Ramírez-Izcoa A, Alvarado-Rivera S, Godoy-Mejía C, Valenzuela-Castillo R. Meningoencefalitis por Cryptococcus neoformans en adolescente con desnutrición. ACTA MEDICA PERUANA [Internet]. 2016 [cited 19 February 2020];33(3):232. Available from: http://www.scielo.org.pe/pdf/amp/v33n3/a11v33n3.pdf
Day J, Chau T, Wolbers M, Mai P, Dung N, Mai N et al. Combination Antifungal Therapy for Cryptococcal Meningitis. New England Journal of Medicine [Internet]. 2013 [cited 19 February 2020];368(14):1291-1302. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1110404
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Array